Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
  • Home
  • venglustat

Tag: venglustat

Infilbray FDA approval venglustat type 3 Gaucher disease infographic
  • Pharmaceuticals

Infilbray FDA Approval: Sanofi Pill Is First to Treat Brain Symptoms of Type 3 Gaucher Disease

Megan Wood48 minutes ago010 mins

The FDA approved Sanofi’s Infilbray (venglustat), the first drug for neurological symptoms of type 3 Gaucher disease, after it beat enzyme therapy in the LEAP2MONO trial.

Read More

Categories

  • Healthcare IT (26)
  • Industry Insights (360)
  • Lifestyle and Wellness (24)
  • Medical Devices (45)
  • Pharmaceuticals (108)
  • Uncategorized (1)

Recent Posts

  • Infilbray FDA Approval: Sanofi Pill Is First to Treat Brain Symptoms of Type 3 Gaucher Disease
  • Pfizer Starna Deal: $330M Upfront Buys Into In Vivo CAR-T for Autoimmune Disease
  • Merck Nemtabrutinib Discontinued: BELLWAVE CLL Program Ends After Safety Review
  • Isomorphic Labs Series C: Inside the $5 Billion Record Bet on AI-Designed Drugs
  • Flagship Pioneering London Lab: £100M Bet on AI-Native Biotech
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.